Atrium Innovations Inc. (ATB)

Atrium Innovations Inc. develops, manufactures, and commercializes science-based and professionally endorsed products for the health and nutrition industry primarily in Canada, the United States, Germany, and the Netherlands. It offers multi-vitamins for adults and children, condition specific formulas, fish oils, and antioxidants, as well as bioavailability platforms, including liposomals, phytosomes, VESIsorbs, cyclo-dextrin, liquids, and liquid-filled capliques under the Pure Encapsulations brand; and enzyme, pre/pro biotic, fatty acids, and other specialty formulas under the Douglas Laboratories brand. The company also provides systemic enzyme-based products under the Wobenzym brand; food supplements, such as probiotics, vitamins, minerals, fatty acids, enzymes, antioxidants, multi-vitamins/minerals, amino acids, phytotherapeutics, other specific preparations, and other condition-specific nutrient formulas under Orthica and AOV brands; and Omega-3 supplements under the Minami brand. In addition, it offers products that address digestion, joint care, cardiovascular health, and general wellbeing under the Nutri Health brand; and vitamins, minerals, and herbal supplements under the Trophic brand. Further, the company also provides vitamin and mineral products, probiotics, Omega-3 fatty acids, weight management products, proteins, meal replacements, herbal extracts, enzymes, and specialty formulas under Garden of Life, Genestra Brands, and Pharmax names; and contract manufacturing services under the Alcrea Health name for health and nutrition products. It distributes its products through healthcare practitioners, and health food and specialized stores. The company was formerly known as Atrium Biotechnologies Inc. and changed its name to Atrium Innovations Inc. in May 2007. Atrium Innovations Inc. was founded in 1999 and is headquartered in Quebec, Canada. As of March 8, 2018, Atrium Innovations Inc. operates as a subsidiary of Nestlé Health Science S.A..